The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 31, 2016
Filed:
Nov. 12, 2012
Applicant:
Osi Pharmaceuticals, Llc, Farmingdale, NY (US);
Inventors:
Meizhong Jin, East Northport, NY (US);
Mridula Kadalbajoo, Farmingdale, NY (US);
An-Hu Li, Commack, NY (US);
Mark J. Mulvihill, Concord, MA (US);
Kam W. Siu, Farmingdale, NY (US);
Arno G. Steinig, Carmel, NY (US);
Jing Wang, Milford, CT (US);
Assignee:
OSI Pharmaceuticals, LLC, Northbrook, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); C07D 475/00 (2006.01); A61K 31/519 (2006.01); C07D 487/04 (2006.01); C07D 471/04 (2006.01); C07D 519/00 (2006.01); A61K 45/06 (2006.01); C07D 475/12 (2006.01); A61K 31/5025 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/4985 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01); C07D 475/00 (2013.01); C07D 475/12 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01); A61K 31/5025 (2013.01);
Abstract
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven or mediated at least in part by RSK. This Abstract is not limiting of the invention.